FindTrial
Sign In

Maintenance

DRUG13 trials

Sponsors

PETHEMA Foundation, University of Arkansas, University of Massachusetts, Boston, Gruppo Italiano Malattie EMatologiche dell'Adulto, University of Colorado, Denver

Conditions

Aged 60 Years or OlderAged Healthy VolunteerCD19+ Acute LeukemiaCardiovascular Disease PreventionChildhood ObesityComplianceDe NovoDepression

Phase 2

UARK 89-001 Phase II Study of Intensive TOTAL THERAPY For Untreated or Minimally Treated Patients With Multiple Myeloma
CompletedNCT00580372
University of ArkansasMultiple Myeloma
Start: 2002-08-31End: 2015-10-31Updated: 2016-09-20
MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate
CompletedNCT02067143
Gruppo Italiano Malattie EMatologiche dell'AdultoDe Novo, Low-dose Corticosteroids Pretreatment, Secondary +1
Start: 2014-05-20End: 2020-12-07Updated: 2021-09-08
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)
CompletedNCT03011528
Institut CurieEwing Sarcoma Family of Tumors
Start: 2016-12-31End: 2023-11-30Updated: 2025-11-21
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
Enrolling by invitationNCT06773936
SWOG Cancer Research NetworkCD19+ Acute Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Start: 2026-05-15End: 2033-07-01Target: 55Updated: 2026-03-04

Phase 3

Pethema Multiple Myeloma 2000
CompletedNCT00560053
PETHEMA FoundationMultiple Myeloma
Start: 2000-01-31End: 2005-02-28Updated: 2008-11-27
High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
Not yet recruitingNCT07129239
Clinique de Retine de l'estWet Age-related Macular Degeneration (wAMD)
Start: 2025-08-20End: 2027-02-28Target: 180Updated: 2025-08-19

Unknown Phase

A Family-Based Weight Loss Intervention for Youth With Intellectual Disability
CompletedNCT02033642
University of Massachusetts, BostonObesity
Start: 2012-08-22End: 2018-01-19Updated: 2019-12-18
Family Matters Intervention
Enrolling by invitationNCT02669797
University of Colorado, DenverCardiovascular Disease Prevention, Childhood Obesity
Start: 2022-02-11End: 2028-04-30Target: 500Updated: 2025-09-22
An Adaptive Intervention for Depression Among Latinos Living With HIV
CompletedNCT03668379
University of California, San FranciscoDepression
Start: 2020-02-26End: 2022-08-28Updated: 2024-10-21
Surgical Protocol for Prevention of Mucositis
NCT04628520
Università Vita-Salute San RaffaeleMucositis
Start: 2018-07-02End: 2021-12-30Target: 51Updated: 2020-11-13
Effect of Periodontal Maintenance Therapy on Tooth Loss in Regular and Irregular Compliant Smokers and Non-Smokers: A Cohort Retrospective Analysis With a Follow-up Up to 40 Years
NCT04938089
Saint-Joseph UniversityCompliance, Periodontal Diseases, Smoking +1
Start: 2022-05-31End: 2022-07-31Target: 160Updated: 2022-04-27
Teleconsultations Hypnosis Sessions for Patients with Peripheral Chronic Neuropathic Pain
CompletedNCT05623449
University Hospital, BordeauxPain, Peripheral Neuropathy
Start: 2023-02-23End: 2024-04-30Updated: 2024-11-25
Physical Fitness, Sleep Quality, Dynamic Balance and Exercise in Aged People
CompletedNCT06646380
Instituto Politécnico de BragançaAged 60 Years or Older, Aged Healthy Volunteer
Start: 2023-09-15End: 2024-09-15Updated: 2024-10-17

Related Papers

Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.
2025-11-17
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial
Universität Zürich, ZORA2025-11-17
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols
JAMA Oncology2025-06-051 citations
Unraveling Long-Term Survival of Multiple Myeloma Patients, the GEM2000 Experience
Blood2024-11-05
Nutrition in Children and Adolescents
Kompass Nutrition & Dietetics2024-10-141 citations
Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
2024-10-082 citations
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
Blood Advances2023-06-0526 citations
Curability of multiple myeloma (MM) based on relative survival rate (RSR) in patients (pts) treated on earlier total therapy (TT) protocols.
Journal of Clinical Oncology2023-06-011 citations
A three-arm randomized controlled trial using ecological momentary intervention, community health workers, and video feedback at family meals to improve child cardiovascular health: the Family Matters study design
BMC Public Health2023-04-186 citations
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia
HemaSphere2022-10-195 citations
S113: NATIONAL PEGASPARGASE-MODIFIED RISK-ORIENTED PROGRAM FOR PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (PH− ALL/LL). GIMEMA LAL 1913 FINAL RESULTS.
HemaSphere2022-06-013 citations
Clinical applicability and prognostic significance of molecular response assessed by fluorescent‐<scp>PCR</scp>of immunoglobulin genes in multiple myeloma. Results from a<scp>GEM</scp>/<scp>PETHEMA</scp>study
British Journal of Haematology2013-10-0328 citations
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
2010-07-2777 citations
Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.
2009-11-0175 citations
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
2009-09-1554 citations
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
2008-07-31356 citations
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.
2008-07-08194 citations